Trade

with

OxiGene Inc
(NASDAQ: OXGN)
AdChoices
2.15
+0.18
+9.14%
After Hours :
2.15
0.00
0.00%

Open

2.05

Previous Close

1.97

Volume (Avg)

1.59M (408.54k)

Day's Range

2.01-2.23

52Wk Range

1.75-5.40

Market Cap.

44.52M

Dividend Rate ( Yield )

-

Beta

2.07

Shares Outstanding

20.71M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 95.00k

    • Net Income

    • -8.28M

    • Market Cap.

    • 44.52M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -14,336.84

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 2.07

    • Forward P/E

    • -2.56

    • Price/Sales

    • 188.68

    • Price/Book Value

    • 1.28

    • Price/Cash flow

    • -1.77

      • EBITDA

      • -8.17M

      • Return on Capital %

      • -60.33

      • Return on Equity %

      • -64.38

      • Return on Assets %

      • -60.33

      • Book Value/Share

      • 1.69

      • Shares Outstanding

      • 20.71M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 6.00

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • -0.84

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 0.00

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 51.25

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 100.00

            • 82.75

            • Pre-Tax Margin

            • -11,896.84

            • 39.38

            • Net Profit Margin

            • -14,336.84

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 18.86

              • 2.92

              • Quick Ratio

              • 18.62

              • 2.35

              • Interest Coverage

              • -

              • 38.02

              • Leverage Ratio

              • 1.06

              • 2.21

              • Book Value/Share

              • 1.69

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -1.24

                • 217.39

                • P/E Ratio 5-Year High

                • -250.18

                • 634.30

                • P/E Ratio 5-Year Low

                • -1.07

                • 124.82

                • Price/Sales Ratio

                • 178.57

                • 9.52

                • Price/Book Value

                • 1.20

                • 8.61

                • Price/Cash Flow Ratio

                • -1.77

                • 50.51

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -64.38

                        (-1,986.40)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • -60.33

                        (-156.50)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • -64.38

                        (-1,986.40)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • -

                      • 117.08k

                      • Inventory Turnover

                      • -

                      • 1.48

                      • Asset Turnover

                      • 0.00

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -8.28M
                      Operating Margin
                      -8,715.79
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -1.77
                      Ownership

                      Institutional Ownership

                      22.41%

                      Top 10 Institutions

                      45.63%

                      Mutual Fund Ownership

                      3.26%

                      Float

                      98.60%

                      5% / Insider Ownership

                      10.44%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Bridgeway Ultra Small Company Fund

                      •  

                        203,600

                      • 159.03

                      • 0.98

                      • Vanguard Total Stock Mkt Idx

                      •  

                        191,662

                      • 0.00

                      • 0.93

                      • Vanguard Extended Market Index Fund

                      •  

                        158,429

                      • 14.32

                      • 0.77

                      • Fidelity Spartan® Extended Mkt Indx Fd

                      •  

                        55,832

                      • 0.00

                      • 0.27

                      • iShares Micro-Cap

                      •  

                        55,534

                      • 0.00

                      • 0.25

                      • FlexShares Mstar US Mkt Factors Tilt ETF

                      •  

                        5,848

                      • 0.00

                      • 0.03

                      • AXA/Lord Abbett Micro Cap Portfolio

                      •  

                        3,718

                      • 0.00

                      • 0.02

                      • Vanguard US Equity Index

                      •  

                        1,284

                      • 0.00

                      • 0.01

                      • Fidelity Spartan® Total Market Idx Fund

                      •  

                        561

                      • 0.00

                      • 0.00

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Perceptive Advisors LLC

                      •  

                        379,200

                      • -24.16%

                      • 1.83

                      • Bridgeway Capital Management, Inc

                      •  

                        203,600

                      • +159.03%

                      • 0.98

                      • Vanguard Group, Inc.

                      •  

                        202,027

                      • +2.88%

                      • 0.98

                      • GRT Capital Partners LLC

                      •  

                        69,800

                      • 0.00%

                      • 0.34

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Speculative Growth

                      Style

                      Small Core

                      OxiGene, Inc., is a biopharmaceutical company. It is engaged in development of vascular disrupting agents (VDAs) for the treatment of cancer.

                      Key People

                      Dr. David Chaplin,PhD

                      CEO/Director/President

                      Frederick W. Driscoll

                      Chairman of the Board/Director

                      Ms. Barbara Riching

                      CFO/Chief Accounting Officer/Vice President

                      Dr. Gerald McMahon,PhD

                      Director

                      Dr. William D. Schwieterman,M.D.

                      Director

                      • OxiGene Inc

                      • 701 Gateway Boulevard

                      • South San Francisco, CA 94080

                      • USA.Map

                      • Phone: +1 650 635-7000

                      • Fax: +1 650 635-7001

                      • oxigene.com

                      Incorporated

                      1988

                      Employees

                      10

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: